Angelique Denis
Lyon, 69003, France
NCT Number: NCT00328419
The antioxidant system of very low birth weight infants is immature. This immaturity is implicated in the pathogenesis of diseases such as bronchopulmonary dysplasia or retinopathy. The main source of oxidant is oxygen, and parenteral nutrition is contaminated with oxidant. Photoprotection decreases the oxidant load infused with parenteral nutrition. In a preliminary study, photoprotection reduced the frequency of pulmonary bronchodysplasia, increased the quantity of enteral nutrition tolerated, and decreased the arterial blood pressure among very low birth weight infants. The aim of this study is to evaluate the impact of photoprotection on oxidant related diseases among very low birth weight infants. This study is a randomized multicenter trial. In the intervention group, photoprotection is applied until the infusion of parenteral nutrition with amber bags, tubing, and syringes. The quality of photoprotection is controlled by measuring malondialdehyde and cysteine after 24 hours of infusion. The control group will receive parenteral nutrition with transparent bags and tubing. The outcomes are evaluated at 36 weeks, and 680 infants will be enrolled, with stratification among centers and gestational age.
Looking for future studies?
Notify Me1 day–6 day
All sexes
Interventional
Not applicable
Lyon, 69003, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
use of photoprotected parenteral nutrition device
Use of standard (transparent) parenteral nutrition device
Time frame: 28 days
Time frame: 36 weeks
Time frame: 28 days and 36 weeks
Time frame: 7 days, 24days, 36 weeks
Time frame: 36 weeks
Time frame: during enteral nutrition
Time frame: 36 weeks
Hospices Civils de Lyon
Other
Consequences of Parenteral Nutrition Photoprotection on the Oxidant Related Diseases Among Extremely Low Birth Weight Infants : A Randomized Controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00005775
Female Urogenital Diseases and Pregnancy Complications, Hyperphagia
Birmingham, Alabama, United States
View Trial DetailsNCT07728760
Female Urogenital Diseases and Pregnancy Complications, Infant, Premature
Bantul, DI. Yogyajarta, Indonesia
View Trial DetailsNCT02863978
Female Urogenital Diseases and Pregnancy Complications, Infant, Premature
Brest, Brittany Region, France
View Trial DetailsNCT05782569
Female Urogenital Diseases and Pregnancy Complications, Infant, Premature
Middlesbrough, United Kingdom
View Trial Details